A Cost-Effectiveness Analysis of the Prostate Cancer Patient Empowerment Program

Abstract

Prostate cancer is the most prevalent cancer among Canadian males, causing adverse effects and increasing healthcare costs. The Prostate Cancer Patient Empowerment Program (PC-PEP) is a home-based intervention aimed at reducing mental distress, improving physical/urinary functions, and enhancing quality of life. This study evaluated PC-PEP’s cost-effectiveness, hypothesizing that early implementation reduces healthcare spending and improves patient outcomes. In a six-month cross-over randomized trial, participants were assigned to PC-PEP or a waitlist control group. PC-PEP included daily stress reduction, fitness routines, pelvic floor exercises, healthy habits, intimacy training, social support and dietary recommendations. Results demonstrated PC-PEP’s cost-effectiveness. At six months, the intervention saved 411.53 CAD per patient and prevented 30% of psychological distress cases while gaining 0.0134 QALYs. At 12 months, savings increased to 660.89 CAD, preventing 31% of psychological distress cases and gaining 0.0344 QALYs. These findings support integrating PC-PEP into clinical practice to reduce costs and improve outcomes.